Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.19 is 22% below its 5-year average of 6.65, near the low end of its 5-year range (5.19–12.64).
As of the fiscal period ended Tuesday, June 30, 2026. 20.64% below its 12-month average of 6.54.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.19.
CURRENT RATIO
5.19
CURRENT RATIO AVG TTM
6.54
CURRENT RATIO AVG 3Y
6.42
CURRENT RATIO AVG 5Y
6.65
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.64%
CURRENT VS 3Y AVG
-19.11%
CURRENT VS 5Y AVG
-21.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+38.43%
vs the sector median at left
Market Cap
$77.54M
Current Ratio
0.14
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.07
Market Cap
$78.07M
Current Ratio
1.00
TTM Avg
2.08
3Y Avg
2.75
5Y Avg
4.86
Market Cap
$79.61M
Current Ratio
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outset Medical, Inc. (OM) | $76.74M | 5.19 | 6.54 | 6.42 | 6.65 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | 0.14 | 0.07 | 0.07 | 0.07 |
| SkinHealth Systems Inc. (SKIN)vs › | $75.95M | 1.76 | 4.33 | 6.41 | 6.77 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | 1.00 | 2.08 | 2.75 | 4.86 |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | 1.98 | 1.80 | 2.98 | 4.38 |
| Pulmonx Corporation (LUNG)vs › | $75.18M | 4.32 | 5.33 | 6.57 | 9.68 |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | 12.48 | 10.44 | 6.35 | 4.73 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | 7.99 | 9.12 | 12.06 | 14.25 |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | 6.15 | 5.25 | 8.81 | 10.73 |
| Humacyte, Inc. (HUMA)vs › | $80.30M | 6.21 | 3.04 | 4.62 | 7.16 |
Current Ratio
5.19
Quick Ratio
4.11
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.19 |
| 2026-03-31 | 6.29 |
| 2025-12-31 | 6.67 |
| 2025-09-30 | 7.09 |
| 2025-06-30 | 7.47 |
| 2025-03-31 | 8.37 |
| 2024-12-31 | 5.69 |
| 2024-09-30 | 6.49 |
| 2024-06-30 | 6.80 |
| 2024-03-31 | 6.42 |
| 2023-12-31 | 5.26 |
| 2023-09-30 | 5.35 |
| 2023-06-30 | 6.34 |
| 2023-03-31 | 7.62 |
| 2022-12-31 | 7.19 |
| 2022-09-30 | 6.24 |
| 2022-06-30 | 6.26 |
| 2022-03-31 | 7.72 |
| 2021-12-31 | 7.93 |
| 2021-09-30 | 10.46 |
| 2021-06-30 | 12.64 |
| 2021-03-31 | 9.24 |
| 2020-12-31 | 9.43 |
| 2020-09-30 | 11.13 |
| 2020-06-30 | 2.98 |
| 2020-03-31 | 7.23 |
| 2019-12-31 | 3.20 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
